Fluxion announces the launch of IonFlux Mercury, its next generation automated patch clamp system.


South San Francisco, Calif. – Fluxion Biosciences announced today the release of a second generation of its IonFlux automated patch clamp family of products.  IonFlux Mercury will  replace and update the existing IonFlux product family. While IonFlux systems were previously  distributed by Molecular Devices, the new product line will be sold direct by Fluxion Biosciences and its partners.

IonFlux systems are being used all over the world in industry and academic laboratories and are well established systems in ligand and voltage gated ion channel screening. Their unique in-plate perfusion providing continuous compound flow allows for the simplification and speed of otherwise complicated and long assays. With IonFlux Mercury, Fluxion takes the platform to a new level by enhancing all aspects of its operation. The platform adds new features such as remote and touch screen experiment execution, highly extended recording times, new streamlined fluid exchange system, standardized temperature control, and integrated current clamp. IonFlux Mercury is most compact yet full featured stand-alone high throughput automated patch clamp instrument on the market. “We believe that the new updates to the IonFlux system will greatly enhance all aspects of an otherwise well proven and unique automated patch clamp system”, explained Dr. Ali Yehia, VP IonFlux Product at Fluxion.  The IonFlux Mercury will replace the IonFlux 16 while the IonFlux Mercury HT will replace the IonFlux HT. Both systems will be sold exclusively by Fluxion Biosciences and are available for pre-ordering now. All IonFlux 16 and HT system sold within this year are upgradeable to Mercury. 

Press ReleaseWeb Admin